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Abstract
Purpose This study explored employer’s perspectives on (1) their experience of good practice related to workers diagnosed with
cancer and their return to work (RTW), and (2) their perceived needs necessary to achieve good practice as reported by employers
from nine separate countries.
Methods Twenty-five semi-structured interviews were held in eight European countries and Israel with two to three employers
typically including HR managers or line managers from both profit and non-profit organisations of different sizes and sectors.
Interviews were recorded and transcribed verbatim. A grounded theory/thematic analysis approach was completed.
Results Employers’ experience with RTWassistance for workers with cancer appears to be a dynamic process. Results indicate
that good practice includes six phases: (1) reacting to disclosure, (2) collecting information, (3) decision-making related to initial
actions, (4) remaining in touch, (5) decision-making on RTW, and (6) follow-up. The exact details of the process are shaped by
country, employer type, and worker characteristics; however, there was consistency related to the need for (1) structured
procedures, (2) collaboration, (3) communication skills training, (4) information on cancer, and (5) financial resources for
realizing RTW support measures.
Conclusions Notwithstanding variations at country, employer, andworker levels, the employers from all nine countries reported that
good practice regarding RTWassistance in workers with a history of cancer consists of the six phases above. Employers indicate that
they would benefit from shared collaboration and resources that support good practice for this human resource matter.
Implications for cancer survivors Further research and development based on the six phases of employer support as a framework
for a tool or strategy to support workers with a history of cancer across countries and organisations is warranted.
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Introduction
Each year, 3.4 million new cases of cancer are diagnosed in
Europe, of which about 1.6 million are of working age [1].
With improvements in diagnosis, treatment, and survival
rates, returning to paid work after cancer diagnosis and treat-
ment has become of increased importance to individuals, em-
ployers, and the wider society [2].
Motivations for return to work (RTW) are based not only
on financial but also on psychological needs as well, because
work often provides meaning to people’s lives [3]. Many stud-
ies have shown that work plays an important role for cancer
survivors’ identity formation, self-esteem, financial security,
and social relationships, and represents capabilities, skills, and
health [4]. Although some people affected by cancer are sim-
ply able to continue working in a similar manner as prior to
diagnosis [5], a significant proportion of them end up unem-
ployed, retire early, or change jobs more often than those
without cancer [6–9]. While 63% of 64 studies of cancer sur-
vivors returned to work [10], one important reason for not
returning to work given by patients is a reported lack of un-
derstanding and support from their employers [11, 12]. This
was also experienced by other stakeholders including insur-
ance institutes, doctors, and persons in the patient’s private life
[13]. Some cancer survivors feel vulnerable and insecure in
relation to RTWand are in need of acknowledgement of their
concerns by their employers [14]. From an employer perspec-
tive, the RTW of knowledgeable and experienced workers
enables continuity of skilled manpower and minimizes costs
due to lost productivity while reducing payment of disability
compensation [15].While there is research on the perspectives
of employers with experience with workers with a history of
cancer [12, 16–18], there is a need to determine whether em-
ployers experience patterns of useful strategies for RTW
across diverse nations.
Evidence suggests that employers have a considerable im-
pact on many aspects of the workers’ wellbeing [19] and that,
as expected, employers play a central role in the success of
RTW. Employers are in a position to make workplace accom-
modations, provide support, and facilitate colleagues or co-
workers [14, 17, 18, 20, 21]. Cancer survivors are more likely
to be employed if they perceived their employer as accommo-
dating and received support from colleagues and employers
[22]. Furthermore, given the central role of the employer in all
matters related to work in a specific organization, nine out of
ten recommendations in the European Declaration call for a
guideline on cancer and work involving the employer [23].
Employers however struggle with this role [12, 16] and are in
need of support to achieve positive outcomes related to work
and cancer survivorship [17, 18].
Therefore, further elaboration of the specific perspectives
from various employers in the return to work process of cancer
survivors may assist in the process of identifying employer
actions that may help improve work outcomes. The aim of
the present study is to obtain a better understanding of the
employers’ experience with good practices related to em-
ployees with a history of cancer and identify specific actions
to achieve positive outcomes.
Methods
The COnsolidated criteria for REporting Qualitative research
(COREQ) Checklist was used for reporting of findings [24].
Sample
Interviews were performed in Belgium, Croatia, Israel, Italy,
the Netherlands, Norway, Slovakia, Romania, and the UK, all
members of the CANcer and Work Network (CANWON)
[25] and representing Eastern, Western, Northern, and
Southern European-style welfare state models or a mix of
these. Using purposive sampling targeting, three employers
per country were approached that together represented the
following characteristics: (a) at least two organisations each
with small (≤ 50 workers), medium (50–500 workers), and
large (> 500 workers) workforce; (b) three different sectors;
and (c) both profit and non-profit organizations. Employers
were approached via professional networks and publically
available contact information. Inclusion criteria for inter-
viewees were (1) employer with experience and close involve-
ment in supporting one or more worker(s) diagnosed with
cancer in the last 5 years, (2) at least two employers per coun-
try with employees with some experience with a co-worker
with cancer who recently returned to work, (3) an organisation
that complies with national legislation, and (4) an employer
fluent in the country’s language.
Data collection
Employer representatives (HRmanagers, line managers) were
contacted either by e-mail, telephone, or face-to-face, and in-
formed about the aim of the study and asked to provide written
or oral informed consent prior to the interview. The interview
guide (see Table 1 for topics) was adapted from Tiedtke et al.
[12] with the authors representing the countries. Interviews
provided a consistent set of questions across countries.
The nine interviewers were researchers or practitioners
who were employed in work or health areas and had experi-
enced conducting interviews. The majority of the interviewers
and interviewees had no established contact prior to the inter-
view and interviews were preferably completed by one inter-
viewee. Interviews were conducted between May 2016 and
March 2017. The interviews lasted 30–60 min, were held in
the interviewers’ and interviewee’s native language, and were
held face-to-face at the workplace or by telephone/Skype
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when necessary for logistical reasons. All interviews were
audio-recorded and transcribed verbatim if the interviewee
agreed. In two cases, a written account of the interview was
produced directly after the interview. Interviews were not
returned to interviewees for comments. Interviews were trans-
lated into English by the interviewer or a co-author from the
same country. Data collected and analysed during the study
are available from the corresponding author upon request.
Sample characteristics
In total, 59 employers were approached (range 3–30 per coun-
try) and 25 interviews were conducted including 27 employer
representatives (response rate 42%). Average age of the inter-
viewees was 48 years, 10/27 were female, 13 were directors or
line managers, and 14 HR or health and safety professionals.
The sizes of the organisations varied between small (n = 5
employers), medium (n = 9 employers), and large (n = 11
employers). Diverse sectors with 6 companies from the indus-
try sector were represented. Fourteen organisations were for-
profit organisations, while the others were non-profit and
mostly public organisations (see Table 2).
Data analysis
Amix of grounded theory [26] and thematic analysis [27] was
adopted, emphasizing collaborative analysis from different
country perspectives; all themes were derived from the data
and none were identified in advance. All interviews (which
had been translated to English, see above) were coded, and a
preliminary overall schematic representation of the interviews
was provided [28] by the first author. Next, all authors read the
interviews completed in their own country in addition to at
least two from another country, produced narrative reviews in
English of these interviews, and went through a process of
rough coding. A meeting with most authors in Milan,
October 2016, was used to collaboratively define preliminary
themes for a more refined coding.
Then more specific coding on the basis of themes (top
down) and data (bottom up) was performed and a first version
of results was produced. The findings were discussed at a
second meeting with authors in Loughborough, January
2017, and a refined overall schematic representation of the
interviews was produced. A second version of the results
was produced based on this meeting.
Table 1 Interview guide
Part of the interview Items and questions
Start Start with explaining goal, anonymity, confidential treatment of interview data.
Background
information
Ask for background information
- Inclusion criteria
- Age and gender
- Function/relation with worker(s) with cancer: line manager, HR manager, other
- # workers (small (50), medium (50–500), large sized (larger than 500))
- Type of organisation (sector and being profit or non-profit organisations)
Questions on
experiences
1. What does ‘being a good employer’ mean according to you in relation to workers
with cancer (with health problems)? (productivity, care, taking care of
financial arrangements….)
(Next focus on dilemmas, uncertainties, good practices in their experiences)
2. How do you know that a worker has cancer? (privacy, trust, disclosure,
communication in organisation)
3. Do you contact the employee, if so, how do you keep contact with the worker?
4. How did it affect your organisation? (replacing, colleagues, clients, money,
worker-relation, legal issues, work accommodations, barriers, facilitators)
5.What solutions did you use? (policy available, decisionmaking bywho, weighing pros
and cons, other actors (trade union, health professionals etc.) involved, barriers (for
RTW))
6.Which solutions would you advice to other employers who have workers with cancer?
(refer to actors in answer question 5, successes, failures, invite to be creative,
lessons learned)
• Interviewer summarizes successful solutions mentioned
Question on needs 7. What kind of resources (info, education, consultancy, financial…) would you want or
what do you think other employers would need to achieve successful solutions you
mentioned? (tools used, link to what they believe is a good employer)
Ending the
interview
Do you have something to add? Would you want to test a tool based on this research?
Thank you!
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Finally, in a third meeting with authors in Bratislava,
March 2017, results were discussed and the final overall sche-
matic presentation of the interviews was established. A final
version of the results was agreed upon via e-mail.
Ethical issues and confidential treatment of data
All procedures performed involving human participants were
in accordance with the ethical standards of the institutional
and/or national research committee and the 1964 Helsinki
Declaration and its later amendments or comparable ethical
standards. Ethical approval was assured and in line with na-
tional standards in each country.
All interviewers informed the participating employers and
asked for their written or oral informed consent and all tran-
scripts were anonymous. The researchers who read, during the
process of data analysis, the anonymous interviews from an-
other country, all signed a statement that they will treat the
transcripts confidentially. Each interviewer who collected the
data was held responsible for treating these data according to
national standards.
Results
Overall, employers viewed the experience of assisting a work-
er with a history of cancer in relation to RTW as a dynamic
process. Six support phases were identified as good practice
for addressing RTWof a worker with a history of cancer. The
support differed in level of comprehensiveness by country,
organisation, employer, and worker. However, the dynamic
process implicated by the expressions of employers across
these nations is summarized in Fig. 1.
Dynamic process
Rather than a procedure that can be simply managed, em-
ployers referred to supporting workers as a process depending
on the specific context.
“But what I always find important it that it is a process
between line manager and worker (…).”
As indicated in Fig. 1, this process typically involves six
different phases: (1) reacting to disclosure by the worker, (2)
line manager obtains more information related to the situation,
Table 2 Characteristics of interviewees
Country/int# Age Gender Function Company size Non-profit/
profit
Sector
1 Belgium 1 56 m HR director Large Non-profit Health and social work
2 Belgium 2 49 m Regional director Large Non-profit Health and social work
3 Belgium 3 47 f Line manager Medium Profit Manufacturing
4 Croatia 1 56 m Trade union director Small Non-profit Education
5 Croatia 2 35 m OHS expert Medium Profit Wholesale and retail trade
6 Croatia 3 52 f OHS expert Large Non-profit Public administration and defence
7 Italy 1 53 m HR director Medium Profit Manufacturing
8 Italy 2 60 m CEO Small Profit Science
9 Italy 3 50; 58 m; m HR and OHS directors Large Profit Manufacturing
10 Israel 1 45 f Department manager Large Non-profit Education
11 Israel 2 53 m Department manager Large Profit Manufacturing
12 Netherlands 1 44 f HR manager Small Profit Education
13 Netherlands 2 48 m Line manager Medium Profit Transportation and storage
14 Netherlands 3 54 f Line manager Large Non-profit Health and social work
15 Norway 1 44 m Line manager Large Profit Construction
16 Norway 2 55 m Administrative director Medium Profit Maritime industry
17 Norway 3 55 f Principal Small Non-profit Education
18 Romania 1 53 m HR manager Small Non-profit Public administration
19 Romania 2 45 f HR manager Medium Non-profit Health and social work
20 Romania 3 38 m HR consultant Large Profit Manufacturing
21 Slovakia 1 35-40 f HR director Medium Profit Manufacturing
22 Slovakia 2 28 f HR manager Medium Profit Information/communication
23 Slovakia 3 40-50 f; m HR and Health managers Large Profit Manufacturing
24 UK 1 N/A m Director Large Non-profit Education
25 UK 2 N/A m Manager Medium Non-profit Health and social work
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(3) decision-making related to initial actions, (4) remaining in
touch during the treatment and/or the sick leave period, (5)
decision-making on RTW, and (6) follow-up. This dynamic
process does not always follow a stepwise method where
phases are not always addressed in the order described and
can be brief or comprehensive. Employers tend to tailor the
process to the situation and person. The needs of a specific
worker are considered and flexibility is a major priority.
“(…) A good employer should pay particular attention
to a serious illnesses like cancer, in order to manage
working time and required tasks in relation to the work-
er. Here’s what I think: (…) the organisation (…) abso-
lutely has to consider every local situation and people
working in the enterprise.”
Phase 1: Reacting to disclosure by the worker of a cancer
diagnosis
Involvement of the employer is only possible if the cancer
diagnosis is disclosed, which is not mandatory according to
privacy legislation across all nations.Most workers do explain
their situation to their employer. Alternatively, the HR depart-
ment, the occupational physician, or the family might discuss
the situation with the line manager, emphasizing confidential-
ity of the information.
“(…) the Human Resources department will normally
contact the head of department (…) to let them
know.(…) within that, there’s advice about not sharing
this information (…)”
The employers consider a worker’s cancer diagnosis to
have a special status compared to other health conditions,
for three reasons. Firstly, the diagnosis is not questioned.
Secondly, “With cancer, one thinks immediately of the risk of
death, and that is what makes it special (…)” and thirdly,
cancer is regarded as psychologically demanding for the
worker. As a consequence, employers often mention that the
diagnosis of cancer facilitates workplace support.
“I believe that cancer is creating something extra
among all the persons around this person (…) com-
pared to (…) musculoskeletal disorders. It [cancer] cre-
ates (…) a greater will to contribute (…) and patience in
relation to the unpredictability.”
Phase 2: Line manager obtains more information related
to the situation
After the cancer diagnosis is disclosed, the employer—mostly
the line manager—begins to obtain relevant information need-
ed for early decision-making, either in the same meeting dur-
ing which the disclosure took place or in additional meetings.
In some countries, an occupational physician meets the work-
er and delivers the information needed. The aim of this phase
is to gain knowledge on the functional consequences of med-
ical situation, the treatment and the psychosocial situation.
Also, contraindications for work at the specific workplace is
DYNAMIC PROCESS
Phase 2. Line manager obtains more  
information related to the situation
Phase 3. Decision-making related 
to initial actions
Phase 4. Remaining in touch during the 
treatment and/or sick leave period
Phase 5. Decision-making on return to work
Phase 6. Follow-up
Phase 1. Reacting to disclosure by the worker 
of a cancer diagnosis
EMPLOYERS’ NEEDS
1) structured procedures; 2) collaboration with stakeholders; 3) communication skills training; 
4) information on cancer; 5) financial resources for return to work
Country variations
FACTORS SHAPING 
THE PROCESS
Variations at the level of
organisation
employer
worker
Fig. 1 The dynamic process of
returning to work after cancer
from the employers’ perspectives
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checked (e.g. amount and type of work demands), and—if
appropriate—determination of whether the commuting time
remains feasible. This phase requires sensitive communication
skills and the willingness to invest time in such discussion.
“It is important to keep a bond with the worker with
cancer and to be there for that worker. Investing time
for this is essential. You should cope with it
consciously.”
Often, employers wait with decision-making until the med-
ical assessment has been completed and the course of treat-
ment becomes clear. If access to health care becomes a prob-
lem, employers might help the worker to obtain medical care
sooner.
Phase 3: Decision-making related to initial actions
After a first impression is made of a worker’s situation, em-
ployers decide whether or not the worker will continue to
work during (waiting for) treatment and if so, under what
conditions. Four types of this initial decision-making process
were reported.
Firstly, the worker might continue working in the same job
under the same conditions. This might involve redistribution
of specific tasks within the team, e.g. strenuous work tasks are
replaced by more simple tasks when the worker’s energy level
is low because of chemotherapy. Furthermore, some flexibil-
ity from the line manager regarding working times can be
required, but this might not be possible when the affected
worker is the manager himself.
“(…) he had to work, because you cannot just not show
up if you are the boss. (…) He worked the entire time,
while I was looking for information or doctors. (…) It
was all physically demanding for him too.”
Secondly, the worker might continue working in adapted
work. For example, shift work may be suspended. Thirdly, the
worker might continue working in a different job with a dif-
ferent contract. Continuing to work can be regarded as bene-
ficial for the worker, yet it is more of an exception than a rule.
Fourthly, the worker may be given sick leave by the occu-
pational or treating physician (depending on the country’s
jurisdiction). Then, an important employer issue is the deci-
sion to replace the worker or not. Some employers suggest
that not replacing the worker represents good practice.
According to them, replacement might be perceived by the
worker as a sign that the job is no longer available for them
and that the employer might possibly not want him or her back
because of impending mortality. However, most employers
indicate that they prefer to avoid such expectations.
“I would like to add, he [the worker] simply must have
the feeling that he has a place to return to, [and not the
feeling] that he is not valued within the company and
that his position will be occupied by someone else.”
This phase of initial decision-making causes employers to
struggle with diverse dilemmas regarding informing and guid-
ing the worker’s colleagues. Firstly, they feel responsible for
safeguarding the privacy of the worker. Secondly, there is the
emotional reaction of the team and this also requires the em-
ployer to take time for communication.
“There is an important impact on the person and on the
team. One has to be on ‘stand by’ for one’s workers.”
Thirdly, lack of replacement for the affected worker might
be a burden to co-workers. In such cases, employers report
using their management/leadership skills to create goodwill in
the team, at least for some time.
Phase 4: Remaining in touch during the treatment and/or sick
leave period
All employers try to keep in touch with their affected workers
in different ways and with different frequencies. There might
be meetings at home or in the organisation, or telephone calls.
The line manager, HR professionals, or occupational physi-
cians might be involved. The goals of this problem solving
includes staying in touch with the worker in order to ensure
that a worker’s needs are clear and to collect necessary infor-
mation on the course of the illness and the treatment via the
worker.
In some countries, a formal plan that for example specifies
proposed work adaptations, counselling, meetings with the
linemanager and occupational physician, and the organization
of phased RTW is required. This plan is written up by the
employer at an early stage and adjusted as needed, and re-
quires regular meetings.
“HR is really strict on providing a plan. There are rou-
tines on that etc. They send out questions that are sup-
posed to be responded to and there must be a written
follow-up plan every fourth week. For example if it is
due on 26th, they follow up soon after.”
Phase 5: Decision-making on RTW
When the effects of treatment on the worker’s work ability
become clear, a more lasting decision for the near future needs
to be made. At this stage, it is not only the employer (line
manager and or HR professional) who decides but depending
on which stakeholders are available in a country; occupational
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physicians, a psychologist in the organisation or community,
social workers, social insurance, and trade unions can also be
involved. Essentially, five possibilities were described by
employers:
1. The worker’s workability is too low and the worker ap-
plies for financial compensation, if available.
2. The worker is on a temporary contract that expires during
treatment. The worker is either out of a job and the in-
volvement of the employer ends or the employer evalu-
ates the situation and tries to identify a job for the worker.
3. The worker himself or herself decides not to continue
working. The employer may find this understandable giv-
en the personal situation of a worker.
4. The worker returns to work part-time, and still receives
some social welfare. The number of work hours may in-
crease over time (depending on whether legislation allows
gradual RTW).
5. The worker returns to work full-time, possibly with adjust-
ments including if feasible the option of working from
home, to reduce demands. If a worker returns to work, the
employer often feels responsible to remove work-related
risks that might negatively affect the worker’s health.
Often, returning to work full-time includes a process of
gradually increasing working hours until the worker is back
full-time (if legislation allows gradual return to work):
“(…) At a certain time, the situation was hardened.
Because, yes, we said, well, you have been ill for a year,
we are going to ‘track 2’, that means, we have to re-
integrate you, thus you have to build up again. That
means that you will return to work slowly, from 20 hours
to 22, 23, 24.”
Phase 6: Follow-up
Employers emphasize that they cannot control the outcome of
the cancer treatment. Some employers report that workers
who returned to work after cancer are still considerably vul-
nerable, which the employer interprets as coming from the
psychological stress of cancer and its treatment.
“It has been three months since she got back (…). The
stress was enormous, she was stressed but never cried,
she functioned but was very stressed, she wanted to
know the results (…).”
Some employers explain that despite their efforts,
RTW appeared not possible because of what they re-
ferred to as the most difficult outcome: death of a work-
er. These employers explain that this was a learning
experience for them and they warn that employers have
to be prepared for this adverse outcome, particularly
because of the negative impact it has on the team.
“And the big difference is when it does not go well.
When death comes. Because then you are stuck in some
kind of a vacuum. And how do you cope with that? (…)
(…) there is a wider dimension (…), and that’s the inter-
personal relationships.”
For this outcome, there are no protocols, but some em-
ployers refer to the important need of support for the line
manager and the whole team, and financial support for the
remaining family.
Factors shaping the RTW process
According to the employers interviewed, how RTW processes
are actually detailed for the affected worker is still a function
of policy related to country, organisation, employer, and
worker.
Country variations
Even though income protection for the work disabled differs
across countries, all employers indicated they try to safeguard
income either by work or welfare. However, large country
differences in the degree of employer involvement in the dif-
ferent RTW phases exist. Policies vary from scarce sickness
absence policies in for example Romania and Slovakia, to
detailed sickness absence policies such as in Norway and the
Netherlands, which require employers to take a large role.
In countries with scarce national policy on sickness ab-
sence, employers choose either taking the primary responsi-
bility or expecting that worker to take the main responsibility.
Employers taking the main responsibility might focus on the
detailed planning of RTW, as in the following quote.
“(…) we are (...) more able to manage it, maybe because
we face very different situations since the health condi-
tions and domestic situations are different for each case.
Since we are in charge, we have to exactly plan how the
situation will develop (...).”
Such employers might also focus on organizing (medical)
support.
“(...) maybe in the sense that if he needs help we (…) can
help with some contacts, help in speeding up the exam-
ination at the doctors, or maybe so that he receives the
best health care that can be provided.”
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Other employers in countries with scarce policy emphasize
being compassionate, i.e. understanding, empathic, or giving
space to the worker diagnosed with cancer, and thereby leav-
ing the responsibility to the worker.
“If they are close to their workers they will find the best
solutions. So it depends on the employer…. If he wants
to help he will eventually find the legal and
organisational ways to help the worker. What matters
is the human side.”
In contrast, in countries with more extensive national pol-
icy on sickness absence, mutual investment by both the em-
ployer and the worker is expected.
“Thus what we always do is look at the full package of
tasks, but I let the person think about it. The person has
to indicate to me: this I will not be able to do, that I will
be able to do. And we try to facilitate that (…) you have
to get people in the mode that they think about this
themselves.”
Employers in these countries describe the process more
precise and in terms of their duties for realizing work accom-
modations and planning gradual RTW.
Variations at the level of the organisation
Within the margins and requirements of national legislation,
organisations also vary in the level of comprehensiveness of
their sickness absence policies and what these policies require
employers to do. These policies vary from a strict policy pre-
scribing employers what to do in different phases to em-
ployers deciding themselves on ad hoc procedures:
“There is a sickness absence protocol. The employer has
to contact the worker every 14 days.”
“(…) we don’t have a procedure about calling the work-
er at home and contacting them on certain dates, and so
on (…). (…) It stays at a personal level, how each of us
knows to manage it; I say it’s about feeling (…)”
Also, the size of the organisation matters. Employers of
smaller companies express a of lack organisational policies
but pictured their organisation as families with strong ties
between the workers. They have great concerns over the risk
of losing their reputation and thus confidence of the consumer,
who often live in their direct environment. Job turnover is rare.
Employers of larger organisations express to have routine sys-
tems in place to manage workers with cancer, and financial
buffers and options to dilute the burden for colleagues. They
have well-developed organisational sickness absence policies
and most have a socio-medical team. However, the flexibility
of larger organisations is sometimes compromised by hierar-
chical decision-making. The RTW process is thus more un-
predictable and flexible in smaller organizations, and might be
more extensively controlled in larger organisations.
Irrespective size or sector, employers refer to different so-
cial cultures in organisations. Some refer to an empathic cul-
ture, in which during each phase, the worker with cancer is
monitored and receives a tailored approach:
“It was less about, look, here’s a policy and do it by
numbers. It was more about actually how are we going
to get the best out of this person now and support them
in their recovery……let them feel that, without becom-
ing sentimental, let them say, look, we care about your
wellbeing,(...).”
Others refer to strictness and maintaining the competitive-
ness of the organisation:
“Brutality is in things and in situations, especially when
the system of costs becomes very strong, as in multina-
tional corporations: if somebody has a cancer, a worker
in HR offices calls him and gives him a redundancy pay
and fires him.”
Finally, some employers explained that RTW is more com-
plicated if during the sickness absence important
organisational changes take place, such as a merger with an-
other organisation.
Variations at the level of the individual employer
The RTW processes also vary because the employers are dif-
ferent people, with different skills, experiences, and character-
istics. Some employers emphasize that their acquired leader-
ship qualities and communication skills had made them fit for
the job of guiding a worker with cancer, and they invest more
effort in each phase.
“It was more about my leadership experience and
treating someone just sensitively. So I had the ability to
say to M., let’s start with you coming back three days a
week and then we’ll work from there, and if you want to
come in a little later (…)”
Other employers have experienced cancer in their personal
lives or with other workers, and feel that because of these
experiences, they feel more secure in the decision-making.
“I knew as I had my mother in that situation.”
Finally, the employer’s personality, “me as a human being”,
influences the extent to which the employer feels emotionally
J Cancer Surviv
affected during the RTW process, varying from protecting them-
selves against becoming too emotional, phrased as “not go down
the basement” to being “affected so much”.
Variations at the level of the worker
Finally, and within the context of national and organizational
policy, most employers take characteristics of the worker into
account when deciding about work adjustments and other
types of support. Workers differ regarding their disease char-
acteristics, personality, and work motivation; their position in
the group; and in their relationship with the employer before
the cancer diagnosis. Workers also differ regarding their emo-
tional reaction and family support. Generally, workers who are
more positively appreciated by their employer can rely on
more employer support.
“(…) not married, (…) and (…) her life revolved around
university and also the team here, (…). So, she was
much more keen to try and come into work. So, that
was a slightly different approach (…).“
Finally, workers in lower job levels can be replaced more
easily when compared with workers with heavy responsibili-
ties. The results presented above identified employers’ expe-
riences of good practice when assisting a worker with cancer
as a phased process, shaped by factors at country, organiza-
tion, and employer and worker level.
Employer needs
Employers report five types of needs across the different coun-
tries in order to better achieve good practice in relation to a
worker with cancer.
Firstly, employers express the need for structured
procedures.
“And I am in favour of procedures and rules and
guidelines.”
As the previous quote illustrates, it is about rules and leg-
islation. Some employers refer to legislation specific for can-
cer patients to fulfil this need.
“Perhaps legislation could help us more. (…) For exam-
ple, the legislation should mention: if they return to work
what you have to do, what one should not do, etc. (…).”
Another option discussed is to have structured procedures
by trade unions in collective bargaining. Furthermore, it is
about organisational policies, which importance is expressed
by employers from countries without and with extensive sick-
ness absence legislation and policies:
“I think it would be very useful to establish return to
work procedures after long sick leave.”
“(…) we have, and most of us [organisations] have
systems to handle it [sickness absence]”. (…) For han-
dling people on sick leave, you must have systems.”
Finally, employers express the need for professional guide-
lines and protocols, based on the literature and knowledge
from practice.
“The employer needs clear instructions on what the
workers can and cannot do, so that they can adjust their
workplaces or give them another job.“
“I would appreciate you forming a working group who
collects experiences and knowledge to formulate a
guideline.”
Secondly, many employers emphasize collaboration with
other stakeholders, among which the role of the occupational
physician or occupational health specialist is highly
appreciated.
“(…) you have to tune things with the social-medical team,
and you need to understand well the responsibility of the
occupational physician and of the line manager. We have
our P&O department involved in the line management
(…) and the HR manager should know and take his re-
sponsibility (…) And I think as being from the P&O de-
partment that he should not check but monitor [the
process].“
“The role of the occupational health specialist is very
important. The occupational health specialist could
come into the company and visit each workplace. The
occupational health specialist makes work ability as-
sessment and draws up an expert opinion about job
tasks in a certain company about what workers can
perform and what cannot be performed anymore.”
Thirdly, most employers refer to communication skills
training.
“A more focused training would be good, or to commu-
nicate with such workers from the perspective of the
employer.”
Fourthly, they also like to get information on cancer and its
treatment side effects, the capabilities of the worker who
returns and possible work adaptations. With such scenarios
of a worker with cancer, then they are better able to deal with
the diverse dilemmas and the emotional burden they experi-
ence as an employer. This can be done via consultation with
experts or an easy-to-access information package according to
employers from diverse countries:
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“Maybe if there was some ‘package’ prepared, which
would summarize all the alternatives in cases of workers
with cancer, to indicate that one doesn’t need to experi-
ence all of it alone. (…) something simple. Which can be
downloaded from the Internet and then distributed to
line managers and colleagues, to see what the different
possibilities are for how it develops.”
Fifthly, employers refer to the need for financial resources
for them to assist workers with cancer.
“I think NGOs could help financially or in another way.
We do not have a union but in other sectors maybe
unions could engage and help in these issues.”
In some countries, the social insurance supports financially.
“We also realized the person could work up to 20% with-
out payment from the company. Social insurance paid this
just to try to get him going and that stimulates.”
These needs fit with the finding that the process of guiding
a worker with cancer is perceived as a dynamic process
consisting of several phases, requiring planning, collabora-
tion, sophisticated communication skills, diverse knowledge,
and financial resources.
Discussion
The aim of this study was to gather different employer per-
spectives on workers with cancer including employers’ expe-
riences of good practice and their perceived needs to support
good RTWoutcomes in these workers. A novel aspect of this
study is that employers were from nine different countries
with different welfare systems.
Despite variations across countries, six phases were identified
by employers with corresponding needs for employer support.
The first phase encompasses the employer’s initial reaction to the
diagnosis. While disclosure of cancer to an employer is not
demanded by law in participating countries, employers felt it
was essential to be informed so that decisions such as temporarily
re-allocating the worker’s job tasks could be made.
Following disclosure, employers gather relevant informa-
tion (phase 2) to help them to decide about initial action (phase
3). While employers used their general managerial skills to
gather relevant information from a worker diagnosed with can-
cer, they expressed the need for more sophisticated communi-
cation skills. The emphasis on advanced communication skills
is in line with previous research in employers managing
workers diagnosed with cancer [16, 17]. During treatment
and/or sickness absence, the employer remains in touch with
the worker (phase 4), again requiring good communication
skills. When a worker’s RTW becomes a possibility, decisions
are made by employers related to RTW and adaptations, and
further planning is needed (phase 5). Finally, employers ad-
dress follow-up of RTW or, in the worst case, of dealing with
advanced, non-curative disease (phase 6).
Employers’ views on good practice are in line with the
scientific literature on how to organize RTW for cancer pa-
tients, including involving problem assessment (including
both the worker and the workplace), planning, performing
planned activities, and evaluation [29]. However, the current
study shows employers put greater emphasis on managing
initial actions and sick leave than on actual RTW. This is
similar to the finding among Belgian breast cancer survivors,
which shows that an intensive mental preparation by workers
preceding actual RTW is important [13]. A Dutch study on
employers managing sick leave and return to work among
workers with cancer reported five phases that reflected nation-
al legislation. However, the current study did not explicitly
distinguish a phase for early information gathering [16].
Collaboration with stakeholders was also expressed as a
need particularly when it comes to designing RTW.
Occupational health physicians, for example, are trained to
translate medical problems into functional issues and fitness
for work. Generally, RTW is regarded a multifaceted process
involving many stakeholders [13–17]. Overall, employers in
the current study expressed a need for structured procedures
consistent with earlier recommendations [18].
The consensus on the phases and needs between the
interviewed employers across countries and organisations is
clearly striking, particularly given differences between countries
on whether employer involvement in RTW is required by legis-
lation as indicated in ‘variations at level of organisation’. The
intensity by which the six phases are addressed was more in-
tense among employers from those countries that have well
developed national RTW guidance or legislation. However, the
current study did not identify ethical dilemmas faced by em-
ployers as found in previous studies [12, 16] such as feeling
caught between their sincere concern for the employee and the
professional realism of interests of the company. This might be
explained by the focus on good practice in the current study.
Strengths and limitations
This is the first study to explore the experiences and needs of
employers regarding workers with cancer across countries
representing diverse welfare models [30]. We selected a wide
variety of employers from different backgrounds and different
sizes and types of companies. All interviewers used the same
interview guide developed collaboratively by the authors,
which increases validity of the data. In addition, during the
analysis, three day-long face-to-face meetings took place with
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the interviewers and data coders (if different) to increase va-
lidity of the analysis [26, 28].
This study has several limitations. Some employers were
selected via professional contacts of the interviewers, and about
half of the employers approached did not participate.
Therefore, selection bias towards a general positive view on
the workability of cancer survivors, both via selection of em-
ployers and via selective report of employers in order to present
a positive image, cannot be ruled out. This is a general difficul-
ty in research on RTW among employers [12, 16, 18, 20].
Indeed, results from survivors’ perceptions show that they are
not always positive on the role of the employer and they can
perceive barriers related to support, communication, work en-
vironment, discrimination, and perception of work ability [17].
The strict selection criteria leading to a balanced composition
of employer types (with also representation of small organisa-
tions) might have counterbalanced this limitation at least partly.
Moreover, we had a response rate of 25/59 of the approached
employers which can have caused a positive selection bias as
well. In addition, a total of 25 interviews might not be many
given that nine countries were involved, but it is not a low num-
ber for qualitative research. Further, although additional informa-
tion could have been provided by additional employers, the con-
sistent findings across countries might be regarded as a sign of
data saturation. Cross-country variations might have impacted
the data from the interviewer’s part. Translation to English might
have led to important linguistic nuances being lost in translation.
This last disadvantage has been counterbalanced by opportunities
for reviewing results by all interviewers. To reduce demands for
employers, they were not asked for any further comments after
the interview questions. To conclude, the findings might not
represent all good practice experienced in each of the nine coun-
tries, but certainly represent an important part of the employer
experiences.
It may not be possible to generalize the findings to coun-
tries not included and countries outside Europe or Israel.
Reliance on the presence of benefits for some level of income
replacement for a worker on sick leave might be the explana-
tion for the high degree of consensus among employers.
Recommendations for further research
Quantitative studies are also needed to substantiate and further
determine the generalization of these findings. It is important
to develop, implement, and study the effectiveness of inter-
ventions aimed at supporting employers in order to enhance
sustainable work participation of workers with a history of
cancer. Effective interventions for this patient group remain
scarce [31]. Finally, more detailed cross-country studies are
needed as other studies do show cross-country variations in
labour participation of vulnerable groups [33–37].
Recommendations for practice
In order to improve the process of RTW in cancer survivors,
employers need support as well [20]. The framework of six
phases found in this study provides policymakers and em-
ployers with a tool to organize new national legislation, com-
pany policy and individual guidance.
Legislation on work adaptations and gradual RTW can aid
employers in supporting RTWof cancer survivors. Across juris-
dictions, there is an increasing focus on supporting individual
participation in the labour force [32]. Finally, our findings indi-
cate the need for training in communication and decision-making
skills of employers related to this problem and perhaps chronic
illness and work in general. Caring for workers with cancer
should be continued beyond the hospital walls and beyond re-
covery of the malignancy. Employers are key to realize this.
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